Back
Can Fite Biofarma Stock Price Chart
Sponsored
CANF
Sponsored
The Next Tech Giant in Your Pocket?
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
42
CANF
Can Fite Biofarma
Last Price:
2.04
Seasonality Move:
6.52%
7 Day Trial
ALL ACCESS PASS
$
7
How to Profit From "America's Earnings" Reports
New Trade Goes LIVE THIS TUESDAY at 2 pm- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CANF is experiencing slight buying pressure.
Can Fite Biofarma Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 2.3 | Sell |
20-day SMA: | 2.3 | Sell |
50-day SMA: | 2.79 | Sell |
200-day SMA: | 2.37 | Sell |
8-day EMA: | 2.27 | Sell |
20-day EMA: | 2.35 | Sell |
50-day EMA: | 2.54 | Sell |
200-day EMA: | 2.6 | Sell |
Can Fite Biofarma Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.11 | Sell |
Relative Strength Index (14 RSI): | 38.23 | Sell |
Chaikin Money Flow: | 5846 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (2.23 - 2.45) | Sell |
Bollinger Bands (100): | (2.12 - 3.14) | Sell |
Can Fite Biofarma Technical Analysis
Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Can Fite Biofarma Stock
Is Can Fite Biofarma Stock a Buy?
- Can Fite Biofarma share price is 2.15 while CANF 8-day simple moving average is 2.30, which is a Sell signal.
- The stock price of CANF is 2.15 while Can Fite Biofarma 20-day SMA is 2.30, which makes it a Sell.
- Can Fite Biofarma 50-day simple moving average is 2.79 while CANF share price is 2.15, making it a Sell technically.
- CANF stock price is 2.15 and Can Fite Biofarma 200-day simple moving average is 2.37, creating a Sell signal.
CANF Technical Analysis vs Fundamental Analysis
Sell
42
Can Fite Biofarma (CANF)
is a Sell
Is Can Fite Biofarma a Buy or a Sell?
-
Can Fite Biofarma stock is rated a Sell
The current Can Fite Biofarma [CANF] share price is $2.15. The Score for CANF is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
Can Fite Biofarma Stock Info
Market Cap:
13.11M
Price in USD:
2.15
Share Volume:
40.92K
Can Fite Biofarma 52-Week Range
52-Week High:
4.69
52-Week Low:
1.81
Sell
42
Can Fite Biofarma (CANF)
is a Sell
Can Fite Biofarma Share Price Forecast
-
What is the Can Fite Biofarma stock price today?
The Can Fite Biofarma stock price is 2.15 USD today. -
Will CANF stock go up or go down?
Can Fite Biofarma> share price is forecast to RISE/FALL based on technical indicators -
Is Can Fite Biofarma overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Can Fite Biofarma is overvalued.
Is Can Fite Biofarma Stock a Buy?
- Can Fite Biofarma share price is 2.15 while CANF 8-day exponential moving average is 2.27, which is a Sell signal.
- The stock price of CANF is 2.15 while Can Fite Biofarma 20-day EMA is 2.35, which makes it a Sell.
- Can Fite Biofarma 50-day exponential moving average is 2.54 while CANF share price is 2.15, making it a Sell technically.
- CANF stock price is 2.15 and Can Fite Biofarma 200-day simple moving average is 2.60, creating a Sell signal.
Fundamental Analysis of Can Fite Biofarma
Is Can Fite Biofarma a good investment?
- Analysts estimate an earnings increase this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.38 per share, and an increase next year of $0.04 per share.
Technical Analysis of Can Fite Biofarma
Should I short Can Fite Biofarma stock?
- CANF Moving Average Covergence Divergence (MACD) indicator is -0.11, suggesting Can Fite Biofarma is a Sell
- Can Fite Biofarma Relative Strength Index (RSI) is 38.23, which suggest Can Fite Biofarma is oversold
- The Bollinger Bands (25) for Can Fite Biofarma is (2.23 - 2.45), which suggest Can Fite Biofarma is a Sell
- The Bollinger Bands (100) for Can Fite Biofarma is (2.12 - 3.14), which suggest Can Fite Biofarma is a Sell
* Can Fite Biofarma stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.